Ainos, Inc.(AIMD)Earnings, Financials & Key Ratios

HOUSTON, TX / ACCESS Newswire / June 22, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today highlighted a new update report published by VASRO GmbH ("VASRO") reviewing Ainos' planned expansion of its AI Nose platform into patient-level breath intelligence. The VASRO update reviews Ainos' recently announced one-year research program with National Taiwan University, scheduled to begin on July 1, 2026, to evaluate whether AI-analyzed breath patterns may help distinguish acute exacerbations of chronic obstructive pulmonary disease ("COPD") from acute decompensated heart failure among patients presenting with shortness of breath.

Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research HOUSTON, TX / ACCESS Newswire / June 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today announced a new research program with National Taiwan University ("NTU") to explore the use of Smell AI in emergency medicine. The program, titled "Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology," will explore the use of Ainos' Smell AI platform to analyze volatile organic compounds ("VOCs") in exhaled breath.